Título:
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
Otros títulos:
Coordinador:
Director:
Compilador:
Autor:
González González, Rogelio
López-Verdín, Sandra
Lavalle-Carrasco, Jesús
Molina-Frechero, Nelly
Isiordia-Espinoza, Mario Alberto
Carreón Burciaga, Ramón Gil
Bologna-Molina, Ronell
López-Verdín, Sandra
Lavalle-Carrasco, Jesús
Molina-Frechero, Nelly
Isiordia-Espinoza, Mario Alberto
Carreón Burciaga, Ramón Gil
Bologna-Molina, Ronell
Tutor:
Tipo de documento:
Artículo
Editor:
Palabras clave:
Ameloblastoma
B-raf proto-oncogene serine/threonine kinase
B-raf protooncogene serine/threonine kinase V600E
Targeted therapies
Additional mutations
B-raf proto-oncogene serine/threonine kinase
B-raf protooncogene serine/threonine kinase V600E
Targeted therapies
Additional mutations
Descriptores:
Año de publicación:
2020
Contenido:
Resumen:
Ameloblastomas are common benign epithelial odontogenic neoplasms that
present an aggressive and unpredictable behavior that may modify treatment
strategies. Different signaling pathways that participate in the progression of
these tumors have been identified. B-raf proto-oncogene serine/threonine kinase
(BRAF) is a protein involved in the behavior of ameloblastomas, and it is related
to many cell mechanisms. BRAF gene mutations have been identified in
ameloblastomas, of which the BRAF V600E (valine substituted by glutamic acid
at amino acid 600) mutation has been the most common and can be present
concomitantly with other mutations that may be involved in its behavior.
Targeted therapies have been used as an alternative in the case of resistance or
contraindications to conventional treatments.
Descripción:
metadata.articulos.dc.description.uri:
Editorial:
EN:
World Journal Clinical Oncology, January 24; 11(1): 31-42, 2020
Financiadores:
Citación:
González González, R, López-Verdín, S, Lavalle-Carrasco, J, y otros. "Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review". World Journal Clinical Oncology. [en línea] January 24; 11(1): 31-42, 2020. DOI: 10.5306/wjco.v11.i1.31
Citación:
metadata.articulos.cc.license.name:
ISBN:
e-ISBN:
ISSN:
2218-4333 (online)
ISMN:
Otros identificadores:
Cobertura geográfica:
Cobertura temporal:
Departamento académico:
Grupo de investigación:
Licencia:
Licencia Creative Commons Atribución - No Comercial (CC - By-NC 4.0)
Colecciones:
| Ficheros | Descripción | Tamaño | Formato | ||
|---|---|---|---|---|---|
| Current concepts 2020.pdf | — | 2.1 MB | Adobe PDF |
